Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
View Patent ↗The present invention features vanilloid receptor polypeptides and vanilloid receptor-related polypeptides, specifically the capsaicin receptor subtypes VR1 and VR2 (VRRP-1), as well as the encoding polynucleotide sequences. In related aspects the invention features expression vectors and host cells comprising such polynucleotides. In other related aspects, the invention features transgenic animals having altered capsaicin receptor expression, due to, for example, the presence of an exogenous wild-type or modified capsaicin receptor-encoding polynucleotide sequence. The present invention also relates to antibodies that bind specifically to a capsaicin receptor polypeptide, and methods for producing these polypeptides. Further, the invention provides methods for using capsaicin receptor, including methods for screening candidate agents for activity as agonists or antagonists of capsaicin receptor activity, as well as assays to determine the amount of a capsaicin receptor-activating agent in a sample. In other related aspects, the invention provides methods for the use of the capsaicin receptor for the diagnosis and treatment of human disease and painful syndromes.
1. A method of screening for an agent that modulates capsaicin receptor function, the method comprising:
a) combining a candidate agent with a eukaryotic cell comprising a recombinant nucleic acid, wherein the recombinant nucleic acid comprises a nucleotide sequence that encodes a biologically active capsaicin receptor polypeptide, which nucleotide sequence is operably linked to a promoter, wherein said capsaicin receptor is encoded by a polynucleotide that hybridizes under stringent hybridization conditions to the complement of a polynucleotide having a nucleotide sequence selected from SEQ ID NO:10, SEQ ID NO:24, and SEQ ID NO:33, and wherein the capsaicin receptor polypeptide is expressed on the cell surface; and
b) determining the effect of said agent on capsaicin receptor function.
2. The method of claim 1 , wherein said determining is by measuring capsaicin receptor-mediated increase in intracellular concentration of a cation.
3. The method of claim 2 , wherein the cation is selected from calcium, magnesium, potassium, cesium, and sodium.
4. The method of claim 2 , wherein the cation is calcium.
5. The method of claim 1 , wherein said determining is by measuring a capsaicin receptor-mediated electrophysiological response.
6. The method of claim 5 , wherein the electrophysiological response is an inward cation-specific current.
7. The method of claim 5 , wherein the response is measured using a fluorescent voltage-sensitive dye.
8. The method of claim 1 , wherein said determining is by measuring blocking the activity of a capsaicin receptor antagonist.
9. The method of claim 8 , wherein the capsaicin receptor antagonist is selected from the group consisting of capsazepine and ruthenium red.
10. The method of claim 1 , wherein said determining is by measuring blocking the activity of a capsaicin receptor agonist.
11. The method of claim 10 , wherein the capsaicin receptor agonist is selected from resiniferatoxin and capsaicin.
12. The method of claim 1 , wherein said determining is by measuring capsaicin receptor-mediated apoptosis.
13. The method of claim 1 , wherein said cell further comprises a reporter gene operably linked to a calcium inducible promoter, and wherein said determining is by measuring calcium-induced expression of the reporter gene.
14. The method of claim 1 , wherein the cell is selected from an amphibian oocyte, a mammalian cell line, and a cultured neuron.
15. The method of claim 1 , wherein the capsaicin receptor is a mammalian capsaicin receptor.